TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Responses So Far Support Outstanding Investigator Grant; NCAB Members Object To Salary commitment July 8, 1983
TCL Archive NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer. January 26, 2001
TCL Archive Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research November 15, 1996
